Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy

AIMS: Glucagon‐like peptide 1 (GLP-1) receptor agonists have demonstrated strong glycemic control. However, few studies have investigated the effects of switching from insulin to GLP-1 receptor agonists. We aimed to investigate, using real-world data, whether switching to dulaglutide improves glycem...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Youngsook, Huh, Ji Hye, Lee, Minyoung, Kang, Eun Seok, Cha, Bong-Soo, Lee, Byung-Wan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248324/
https://www.ncbi.nlm.nih.gov/pubmed/35784534
http://dx.doi.org/10.3389/fendo.2022.880164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248324/
https://www.ncbi.nlm.nih.gov/pubmed/35784534
http://dx.doi.org/10.3389/fendo.2022.880164

Ejemplares similares